annual operating expenses:
$196.24M+$31.27M(+18.96%)Summary
- As of today (September 17, 2025), AVDL annual total operating expenses is $196.24 million, with the most recent change of +$31.27 million (+18.96%) on December 31, 2024.
- During the last 3 years, AVDL annual operating expenses has risen by +$110.64 million (+129.25%).
- AVDL annual operating expenses is now at all-time high.
Performance
AVDL Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$52.88M+$2.94M(+5.90%)Summary
- As of today (September 17, 2025), AVDL quarterly total operating expenses is $52.88 million, with the most recent change of +$2.94 million (+5.90%) on June 1, 2025.
- Over the past year, AVDL quarterly operating expenses has increased by +$1.42 million (+2.76%).
- AVDL quarterly operating expenses is now at all-time high.
Performance
AVDL quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
AVDL Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.0% | +2.8% |
| 3 y3 years | +129.3% | +102.6% |
| 5 y5 years | +207.0% | +374.2% |
AVDL Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +129.3% | at high | +218.0% |
| 5 y | 5-year | at high | +268.5% | at high | +374.2% |
| alltime | all time | at high | +1353.6% | at high | +1502.4% |
AVDL Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $52.88M(+5.9%) |
| Mar 2025 | - | $49.94M(+2.1%) |
| Dec 2024 | $196.24M(+19.0%) | $48.90M(+10.6%) |
| Sep 2024 | - | $44.20M(-14.1%) |
| Jun 2024 | - | $51.46M(-0.5%) |
| Mar 2024 | - | $51.69M(+18.4%) |
| Dec 2023 | $164.97M(+73.3%) | $43.66M(+5.4%) |
| Sep 2023 | - | $41.41M(-17.8%) |
| Jun 2023 | - | $50.40M(+81.9%) |
| Mar 2023 | - | $27.71M(+22.4%) |
| Dec 2022 | $95.22M(+11.2%) | $22.63M(+36.1%) |
| Sep 2022 | - | $16.63M(-36.3%) |
| Jun 2022 | - | $26.10M(-8.0%) |
| Mar 2022 | - | $28.37M(+23.7%) |
| Dec 2021 | $85.60M(+60.7%) | $22.93M(-9.9%) |
| Sep 2021 | - | $25.47M(+17.2%) |
| Jun 2021 | - | $21.74M(+48.4%) |
| Mar 2021 | - | $14.65M(+5.6%) |
| Dec 2020 | $53.25M(-16.7%) | $13.87M(+1.4%) |
| Sep 2020 | - | $13.67M(+22.6%) |
| Jun 2020 | - | $11.15M(-17.0%) |
| Mar 2020 | - | $13.44M(-12.8%) |
| Dec 2019 | $63.92M(-56.3%) | $15.42M(+20.0%) |
| Sep 2019 | - | $12.86M(-24.6%) |
| Jun 2019 | - | $17.05M(-4.1%) |
| Mar 2019 | - | $17.77M(-39.3%) |
| Dec 2018 | $146.31M(+52.5%) | $29.29M(-19.2%) |
| Sep 2018 | - | $36.23M(-8.8%) |
| Jun 2018 | - | $39.73M(+15.4%) |
| Mar 2018 | - | $34.44M(-2.1%) |
| Dec 2017 | $95.94M(+3.5%) | $35.18M(+79.0%) |
| Sep 2017 | - | $19.66M(+2.3%) |
| Jun 2017 | - | $19.22M(+1.1%) |
| Mar 2017 | - | $19.02M(-21.3%) |
| Dec 2016 | $92.68M(+54.8%) | $24.16M(-1.7%) |
| Sep 2016 | - | $24.59M(+30.1%) |
| Jun 2016 | - | $18.89M(+27.2%) |
| Mar 2016 | - | $14.85M(+24.1%) |
| Dec 2015 | $59.88M(+33.8%) | $11.97M(+1.5%) |
| Sep 2015 | - | $11.79M(-9.8%) |
| Jun 2015 | - | $13.08M(+24.7%) |
| Mar 2015 | - | $10.48M(+7.8%) |
| Dec 2014 | $44.74M(+53.3%) | $9.73M(-12.6%) |
| Sep 2014 | - | $11.13M(+0.9%) |
| Jun 2014 | - | $11.04M(+47.9%) |
| Mar 2014 | - | $7.46M(-35.9%) |
| Dec 2013 | $29.18M | $11.64M(+21.2%) |
| Sep 2013 | - | $9.61M(-4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $10.01M(-9.2%) |
| Mar 2013 | - | $11.02M(+19.1%) |
| Dec 2012 | $28.71M(-20.0%) | $9.26M(+1.0%) |
| Sep 2012 | - | $9.16M(-13.8%) |
| Jun 2012 | - | $10.63M(+8.9%) |
| Mar 2012 | - | $9.77M(+7.6%) |
| Dec 2011 | $35.90M(-10.3%) | $9.08M(+12.5%) |
| Sep 2011 | - | $8.06M(-4.8%) |
| Jun 2011 | - | $8.47M(-50.3%) |
| Mar 2011 | - | $17.04M(+78.6%) |
| Dec 2010 | $40.02M(-8.5%) | $9.54M(-1.0%) |
| Sep 2010 | - | $9.63M(-9.6%) |
| Jun 2010 | - | $10.66M(+4.6%) |
| Mar 2010 | - | $10.19M(-21.1%) |
| Dec 2009 | $43.75M(+3.7%) | $12.92M(+16.0%) |
| Dec 2008 | $42.18M(-29.9%) | - |
| Sep 2008 | - | $11.14M(-11.9%) |
| Jun 2008 | - | $12.65M(-5.3%) |
| Mar 2008 | - | $13.35M(+0.8%) |
| Dec 2007 | $60.18M(+8.2%) | $13.25M(-5.6%) |
| Sep 2007 | - | $14.03M(-21.0%) |
| Jun 2007 | - | $17.76M(+21.1%) |
| Mar 2007 | - | $14.66M(-1.5%) |
| Dec 2006 | $55.61M(-10.1%) | $14.89M(+4.8%) |
| Sep 2006 | - | $14.21M(+18.7%) |
| Jun 2006 | - | $11.96M(+1.2%) |
| Mar 2006 | - | $11.82M(-29.8%) |
| Dec 2005 | $61.84M(+43.9%) | $16.83M(+16.0%) |
| Sep 2005 | - | $14.51M(-4.2%) |
| Jun 2005 | - | $15.15M(-1.3%) |
| Mar 2005 | - | $15.35M(+20.6%) |
| Dec 2004 | $42.97M(+64.1%) | $12.73M(+23.3%) |
| Sep 2004 | - | $10.32M(+1.2%) |
| Jun 2004 | - | $10.20M(+4.8%) |
| Mar 2004 | - | $9.73M(-36.4%) |
| Dec 2003 | $26.19M(+61.1%) | $15.31M(+154.2%) |
| Sep 2003 | - | $6.02M(0.0%) |
| Jun 2003 | - | $6.02M(+24.0%) |
| Mar 2003 | - | $4.86M(-4.5%) |
| Dec 2002 | $16.26M(+15.5%) | $5.08M(+38.2%) |
| Sep 2002 | - | $3.68M(-5.7%) |
| Dec 2001 | $14.08M(-44.3%) | - |
| Dec 2000 | $25.26M(+58.3%) | - |
| Dec 1999 | $15.95M(+4.4%) | - |
| Dec 1998 | $15.28M(+9.1%) | - |
| Mar 1998 | - | $3.90M(+18.2%) |
| Dec 1997 | $14.00M(+3.7%) | - |
| Dec 1996 | $13.50M | - |
| Mar 1996 | - | $3.30M |
FAQ
- What is Avadel Pharmaceuticals plc annual total operating expenses?
- What is the all time high annual operating expenses for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc annual operating expenses year-on-year change?
- What is Avadel Pharmaceuticals plc quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc quarterly operating expenses year-on-year change?
What is Avadel Pharmaceuticals plc annual total operating expenses?
The current annual operating expenses of AVDL is $196.24M
What is the all time high annual operating expenses for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high annual total operating expenses is $196.24M
What is Avadel Pharmaceuticals plc annual operating expenses year-on-year change?
Over the past year, AVDL annual total operating expenses has changed by +$31.27M (+18.96%)
What is Avadel Pharmaceuticals plc quarterly total operating expenses?
The current quarterly operating expenses of AVDL is $52.88M
What is the all time high quarterly operating expenses for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high quarterly total operating expenses is $52.88M
What is Avadel Pharmaceuticals plc quarterly operating expenses year-on-year change?
Over the past year, AVDL quarterly total operating expenses has changed by +$1.42M (+2.76%)